MedTrace Logo

Description of Iron Status in Blood Donors

NCT00662285 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2008-04-21

No results posted yet for this study

Summary

Description of the effect of standard iron supplement on iron status in blood donors

Hypothesis:

For each person in each group (group a "without iron supplement" or group b "with iron supplement") individual biological variation in reticulocytes, tested day 1 and day 8 will be described. Groups a and b will be compared on iron status from day 1 and day 8.

* H1 null: There is no significant intraindividual difference in reticstatus at day 1 and at day 8, in group a.
* H2 null: There is no significant intraindividual difference in reticstatus at day 1 and at day 8, in group b
* H3 null: There is no significant difference in iron status for the two groups, a and b, at day 1 and at day 8.

Conditions

Interventions

DIETARY_SUPPLEMENT

Iron supplement: Niferex 100 mg

A: 100 mg pr day in 8 days

Sponsors & Collaborators

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Anne S Røsvik · Aalesund University College

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2008-04-30
Completion
2009-04-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00662285 on ClinicalTrials.gov